Alberta Di Pasquale

2.1k total citations · 2 hit papers
25 papers, 1.5k citations indexed

About

Alberta Di Pasquale is a scholar working on Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Alberta Di Pasquale has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Health, 14 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Alberta Di Pasquale's work include Vaccine Coverage and Hesitancy (17 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Influenza Virus Research Studies (8 papers). Alberta Di Pasquale is often cited by papers focused on Vaccine Coverage and Hesitancy (17 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Influenza Virus Research Studies (8 papers). Alberta Di Pasquale collaborates with scholars based in Belgium, Italy and India. Alberta Di Pasquale's co-authors include Nathalie Garçon, Fernanda Tavares Da Silva, Scott Preiss, Béatrice Laupèze, Arnaud M. Didierlaurent, Catherine Collignon, Ashish Agrawal, Roy K. Philip, Lawrence R. Stanberry and Paolo Bonanni and has published in prestigious journals such as BMC Public Health, Journal of Medical Internet Research and Vaccine.

In The Last Decade

Alberta Di Pasquale

23 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccine Adjuvants: from 1920 to 2015 and Beyond

2015 466 citations Alberta Di Pasquale, Fernanda Tavares Da Silva et al. Vaccines profile →
Adjuvant system AS01: helping to overcome the challenges of modern vaccines

2016 368 citations Arnaud M. Didierlaurent, Béatrice Laupèze et al. Expert Review of Vaccines profile →

Peers

Countries citing papers authored by Alberta Di Pasquale

Since Specialization

Citations

This map shows the geographic impact of Alberta Di Pasquale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberta Di Pasquale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberta Di Pasquale more than expected).

Fields of papers citing papers by Alberta Di Pasquale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberta Di Pasquale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberta Di Pasquale. The network helps show where Alberta Di Pasquale may publish in the future.

Co-authorship network of co-authors of Alberta Di Pasquale

This figure shows the co-authorship network connecting the top 25 collaborators of Alberta Di Pasquale. A scholar is included among the top collaborators of Alberta Di Pasquale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberta Di Pasquale. Alberta Di Pasquale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of Digital Opinion Leaders in Dengue Prevention Through Health Promotion and Public Health Collaboration: Qualitative Semistructured Interview Study 2025 ·Journal of Medical Internet Research ·Andrew Green, (unknown), Alberta Di Pasquale, Tikki Pang	0
2	A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health 2025 ·Vaccines ·(unknown), (unknown), Roberto Dias de Oliveira, (unknown), (unknown), Alberta Di Pasquale, (unknown), (unknown), (unknown), Júlio Croda	0
3	Sustainable Dengue Prevention and Management: Integrating Dengue Vaccination Strategies with Population Perspectives 2024 ·Vaccines ·Asrul Akmal Shafie, Edson Duarte Moreira, Gabriela Pereira Vidal, Alberta Di Pasquale, Andrew R. Green, (unknown), Joanne Yoong	3
4	Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: A scoping review and call to action 2024 ·International Journal of Infectious Diseases ·Mark Doherty, Alberta Di Pasquale, (unknown), (unknown), Roy K. Philip	10
5	Knowledge, Attitudes and Practices toward Dengue Fever, Vector Control, and Vaccine Acceptance Among the General Population in Countries from Latin America and Asia Pacific: A Cross-Sectional Study (GEMKAP) 2023 ·Vaccines ·Asrul Akmal Shafie, Edson Duarte Moreira, Alberta Di Pasquale, Dirk Demuth, Joanne Yoong	21
6	The need for vaccination in adults with chronic (noncommunicable) diseases in India – lessons from around the world 2022 ·Human Vaccines & Immunotherapeutics ·Agam Vora, Alberta Di Pasquale, (unknown), Ashish Agrawal, (unknown)	7
7	Vaccination in Older Adults: An Underutilized Opportunity to Promote Healthy Aging in India 2021 ·Drugs & Aging ·Agam Vora, Alberta Di Pasquale, (unknown), Ashish Agrawal	5
8	Vaccine Hesitancy as a Challenge or Vaccine Confidence as an Opportunity for Childhood Immunisation in India 2020 ·Infectious Diseases and Therapy ·Ashish Agrawal, (unknown), Alberta Di Pasquale, (unknown), Ashish Mathur	46
9	Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review) 2019 ·Gerontology ·T. Mark Doherty, Alberta Di Pasquale, Jean‐Pierre Michel, Giuseppe Del Giudice	8
10	Towards adult vaccination in India: a narrative literature review 2019 ·Human Vaccines & Immunotherapeutics ·(unknown), Ashish Agrawal, Vasant Nagvekar, (unknown), Alberta Di Pasquale, (unknown), Raunak Parikh	29
11	Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting 2019 ·BMC Public Health ·Fiona Ecarnot, Gaetano Crepaldi, Philippe Juvin, John D. Grabenstein, Giuseppe Del Giudice, Litjen Tan, (unknown), Susanna Esposito, Xavier Bosch, G. Gavazzi, John Papastergiou, J. Gaillat, Robert W. Johnson, Marco Fonzo, Andrea Rossanese, Caterina Suitner, Jane Barratt, Alberta Di Pasquale, Stefania Maggi, Jean‐Pierre Michel	51
12	Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood 2019 ·Vaccine ·Béatrice Laupèze, Caroline Hervé, Alberta Di Pasquale, Fernanda Tavares Da Silva	40
13	Life-course immunization as a gateway to health 2018 ·Expert Review of Vaccines ·Roy K. Philip, Katie Attwell, Thomas Breuer, Alberta Di Pasquale, Pier Luigi Lopalco	44
14	Vaccination programs for older adults in an era of demographic change 2018 ·European Geriatric Medicine ·Mark Doherty, Mark P. Connolly, Giuseppe Del Giudice, Johan Flamaing, Jörg J. Goronzy, Beatrix Grubeck‐Loebenstein, Paul‐Henri Lambert, Stefania Maggi, Janet E. McElhaney, Hideaki Nagai, William Schaffner, Ruprecht Schmidt‐Ott, Edward E. Walsh, Alberta Di Pasquale	37
15	Vaccine safety evaluation: Practical aspects in assessing benefits and risks 2016 ·Vaccine ·Alberta Di Pasquale, Paolo Bonanni, Nathalie Garçon, Lawrence R. Stanberry, Mostafa Abdel-Aziz El-Hodhod, Fernanda Tavares Da Silva	85
16	From discovery to licensure, the Adjuvant System story 2016 ·Human Vaccines & Immunotherapeutics ·Nathalie Garçon, Alberta Di Pasquale	165
17	Adjuvant system AS01: helping to overcome the challenges of modern vaccines breakdown → 2016 ·Expert Review of Vaccines ·Arnaud M. Didierlaurent, Béatrice Laupèze, Alberta Di Pasquale, (unknown), Catherine Collignon, Nathalie Garçon	368
18	Safety assessment of adjuvanted vaccines: Methodological considerations 2015 ·Human Vaccines & Immunotherapeutics ·Fernanda Tavares Da Silva, Alberta Di Pasquale, Juan Pablo Yarzábal, Nathalie Garçon	32
19	Cómo abordar la amenaza de la pandemia de gripe: la experiencia con la vacuna H5N1 adyuvada con AS03* 2009 ·Alberta Di Pasquale, Nathalie Garçon, Emmanuel Hanon	2
20	Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres 2002 ·Vaccine ·P Dentico, Pietro Crovari, Piero Luigi Lai, (unknown), Assad Safary, (unknown), François Meurice, Alberta Di Pasquale, Nadia Tornieporth, Anna Rita Volpe, Giancarlo Icardi	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact